Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Bailard Inc.
Bailard Inc. lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 26.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,840 shares of the biopharmaceutical company’s stock after acquiring an additional 2,486 shares during the quarter. Bailard […]